Multiphonon-coupling yellow laser in Yb:La2CaB10O19 crystal.

Yellow lasers at 590 nm have many extensive applications in our daily life, but extremely difficult to attain by traditional solid-state laser technology, owing to the absence of highly-efficient transition channels at this spectral range. In this work, we proposed a cooperative lasing mechanism to obtain the yellow light emission, with multiphonon-assisted electronic transitions and phase-matched frequency-doubling. Based on the predictable configurational coordinate model, we can calculate the multiphonon-assisted emission step-by-step. Using Yb3+-doped La2CaB10O19 crystal as an example, it is capable of producing yellow laser at 581-590 nm, with a maximum output power of 4.83 W and a high slope efficiency of 31.6%. To the best of our knowledge, it represents the highest power of solid-state yellow laser realized in one single crystal pumped by a laser diode. This power scaling can be assigned to the amplified phonon-assisted emission beyond the fluorescence spectrum, and optimized crystal angle for phase-matching condition. Such a compact, low-cost, and high-power laser device, provides an alternative candidate for the spectral "yellow-gap" where no practical solid-state laser exists at present.

Application of TiLOOP bra in implant-based breast reconstruction is associated with decreased complication risk compared with other meshes: A systematic review and meta-analysis.

BACKGROUND: TiLOOP bra has been used for over 15 years, however, evidence regarding its safety in implant-based breast reconstruction (IBBR) for patients with breast cancer after mastectomy is still limited. We performed this meta-analysis to evaluate its risks and benefits in IBBR comparing with other meshes. METHODS: Electronic databases were searched to identify relevant studies comparing postoperative complications between TiLOOP bra and other reconstruction techniques in IBBR with or without meshes. We also compared patient satisfaction in physical well-being between two groups. Risk ratios (RRs) and mean differences with 95% confidence interval (CI) were calculated. RESULTS: Seven studies representing 1203 cases were analyzed. Compared with other meshes, the use of TiLOOP bra significantly reduced the risk of infection (RR = 0.53, 95% CI, 0.32-0.86), seroma (RR = 0.21, 95% CI, 0.07-0.61), red breast syndrome (RR = 0.10, 95% CI, 0.02-0.45), and capsular contracture (RR = 0.20, 95% CI, 0.05-0.75). Patient satisfaction in physical well-being was comparable between two groups. CONCLUSIONS: TiLOOP bra in IBBR has a favored safety profile over other meshes, which significantly reduced postoperative complication risk and did not affect patient satisfaction. Although prospective well-designed controlled studies are still warranted, TiLOOP bra is safe and reliable at present.

5.32 W ultraviolet laser generation at 266†nm using sum-frequency method with CsB3O5 crystal.

Ultraviolet (UV) beam generation at 266 nm using the sum-frequency (SFG) method with CsB3O5 (CBO) crystals was first suggested in 1997 [Opt. Lett.22, 1840 (1997).10.1364/OL.22.001840]; however, there has been no further research in the past 25 years. Herein, by sum-frequency mixing in CBO crystals, we obtained a high conversion efficiency picosecond (ps) and a high-power nanosecond (ns) 266 nm UV beam output. First, a ps laser device with simultaneously radiated wavelengths of 1064 and 355 nm and repetition frequency of 10 Hz was used as the fundamental laser source, and the conversion efficiency from 1064 + 355 nm to 266 nm reached 20.35%. We then used a 1064 nm ns laser with a high output power and repetition frequency of 10 kHz as the pump source. We accurately modified the optimal phase matching direction of the CBO crystal, and the achieved output power at 266 nm reached 5.32 W.

Improvement on Magnetocaloric Effect through Structural Evolution in Gadolinium Borate Halides Ba2Gd(BO3)2X (X = F, Cl).

A new Gd3+-containing borate Ba2Gd(BO3)2F has been successfully grown via the high-temperature solution method using BaF2-NaF-B2O3 flux. Ba2Gd(BO3)2F crystallizing in the orthorhombic space group Pnma is with lattice parameters a = 7.571(4) Å, b = 10.424(5) Å, c = 8.581(4) Å, α = ß = γ = 90°, and Z = 2. Its three-dimensional framework was constructed from interesting pinwheel-like [Gd(BO3)F]∞ layers bridged by sharing [BO3]3-, which is different from the [Gd(BO3)]∞ layer in the model structure Ba2Gd(BO3)2Cl. The magnetic measurements indicated that Ba2Gd(BO3)2F has a larger magnetocaloric effect with -ΔSm,max = 27.82 J·kg-1·K-1at 2 K and 9 T than that of Ba2Gd(BO3)2Cl under the same conditions. Moreover, thermal stability, infrared spectrum (IR), and ultraviolet-visible-near-infrared diffuse reflectance spectrum were carried out to characterize the title compounds. The first-principles computations also looked into the electronic band structures, densities of states, and refractive indices.

Sr14.06Gd14.63(BO3)24: A Gadolinium-Rich Borate with Magnetic Refrigeration Performance.

A single crystal of Sr14.06Gd14.63(BO3)24 has been successfully grown through a high-temperature solution technique with K2O-KF-B2O3 as the flux. It crystallizes in the Pnma space group with parameters a = 22.3153(5) Å, b = 15.9087(4) Å, c = 8.7507(2) Å, and Z = 2. Sr14.06Gd14.63(BO3)24 has a three-dimensional (3D) framework built from [GdO] chains, in which the isolate [BO3]3- groups and Sr2+ ions fill in the space of the 3D framework. The magnetic measurements revealed that the title compound exhibits a large magnetocaloric effect with the magnetic entropy change of -ΔSm = 42.2 J kg-1 K-1 at 2 K for 7 T, which is higher than that of the commercial material, Gd3Ga5O12 (GGG), with -ΔSm of 38.4 J kg-1 K-1 under the same conditions. Moreover, the infrared spectrum (IR), UV-vis-NIR diffuse reflectance spectrum, and thermal stability were investigated.

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status.

BACKGROUND: HER2-low breast cancers were reported to have distinct clinicopathological characteristics from HER2-zero; however, the difference in their genetic features remains unclear. This study investigated the clinical and molecular features of breast tumors according to HER2 status. METHODS: We analyzed the clinicopathological and genomic data of 523 Chinese women with breast cancer. Genomic data was generated by targeted next-generation sequencing (NGS) of breast tumor samples using a commercial 520 gene panel. The cohort was stratified according to HER2 status as HER2-zero (n = 90), HER2-low (n = 231), and HER2-positive (n = 202) according to their immunohistochemistry and fluorescence in situ hybridization results. RESULTS: HER2-low breast tumors were enriched with hormone receptor-positive tumors, and who had lower Ki67 expression levels. Genes were differentially mutated across HER2 subgroups. HER2-low tumors had significantly more mutations involved in PI3K-Akt signaling than HER2-positive (p < 0.001) and HER2-zero breast tumors (p < 0.01). HER2-zero tumors had more mutations in checkpoint factors (p < 0.01), Fanconi anemia (p < 0.05), and p53 signaling and cell cycle pathway (p < 0.05) compared to HER2-low breast tumors. Compared with HER2-zero tumors, HER2-low tumors had significantly lower pathological complete response rates after neoadjuvant therapy (15.9% vs. 37.5%, p = 0.042) and proportion of relapsed/progressed patients across follow-up time points (p = 0.031), but had comparable disease-free survival (p = 0.271). CONCLUSION: Our results demonstrate the distinct clinical and molecular features and clinical outcomes of HER2-low breast tumors.

Diode-pumped continuous-wave laser of a self-frequency-doubling Yb:La2CaB10O19 crystal.

We report the first, to the best of our knowledge, laser operation of acentric Yb3+-doped La2CaB10O19 (Yb:LCB) crystal since its discovery in 1998. The polarized absorption and emission cross-section spectra of Yb:LCB were calculated at room temperature. Using a fiber-coupled 976 nm laser diode (LD) as the pump source, we realized effective dual-wavelength laser generation at around 1030 and 1040 nm. The highest slope efficiency of 50.1% was obtained in the Y-cut Yb:LCB crystal. In addition, via resonant cavity design on a phase-matching crystal, a compact self-frequency-doubling (SFD) green laser at 521 nm was also realized in a single Yb:LCB crystal with an output power of 152 mW. These results promote Yb:LCB as a competitive multifunctional laser crystal, especially for highly integrated microchip laser devices ranging from the visible to the near-infrared regime.

Enhanced Electron-Phonon Coupling Effect in Rare-Earth Borate Crystals Containing a "Quasi-Free-Oxygen" Motif.

Revealing the interaction between electrons and phonons, e.g., electron-phonon coupling or decoupling, is a great challenge for physics and functional material communities. For rare-earth single crystals, the electron-phonon coupling and fluorescence behaviors strongly depend on the crystal structure and constituent motifs. Here, we proposed a universal "quasi-free O" as an effective structural motif to enhance phonon-assisted electronic transitions and photoluminescence. Using Gd3+ ion as a probe, we studied Gd:La2CaB10O19 (Gd:LCB) and GdMgB5O10 (GdMB) crystals composed of double B-O layers and dangling "quasi-free O", respectively, which enable strengthened phonon-involved luminescence. Especially, a GdMB crystal features an infinite [O-Gd-O-Gd-O] chain (O represents quasi-free oxygen), thus greatly promoting the energy transfer and electron-phonon coupling effect. As a result, its Huang-Rhys S factor is two times larger than that of a Gd:LCB crystal under room temperature. These results put forward "quasi-free O" to improve the electron-phonon coupling intensity and allow LCB and GdMB crystals to serve as potential hosts for phonon-terminated vibronic lasers.

Anion-Centered Polyhedron Strategy for Strengthening Photon Emission Induced by Electron-Phonon Coupling.

Electron-phonon coupling emerges as a growing frontier in the heart of condensed matter from physical symmetry to the electronic quantum state, but its quantitative strength dependence on the chemical structure has not been assessed. Here, we originally proposed the anion-centered polyhedron (ACP) strategy for elaborating the electron-phonon coupling interaction in rare-earth (RE) materials comprising three chemical factors, RE-O bond length, the effective charge of the coordinated atom, and structural dimensionality. Using Gd3+ cation with 4f7 configuration as a fluorescence probe, we found that the "free-O"-centered polyhedron is the most crucial motif in strengthening the phonon-assisted energy transfer and photon emission. The temperature-dependent Huang-Rhys S factors were calculated to identify the electron-phonon coupling intensity based on the fluorescence spectrum quantitatively. Finally, beyond conventional wisdom, a series of structural criteria were presented, serving as useful guidelines for discovering strongly coupled rare-earth optical materials. Our study breaks the long-time "blind"-searching diagram and provides reliable principles for many functional materials associated with electron-phonon coupling, such as superconductors, multiferroics, and phosphors.

Submuscular Implant-Based Breast Reconstruction Using a Musculofascial Pocket Formed by the Pectoralis Major Muscle and the Serratus Anterior Muscle Fascia: A Novel Surgical Approach.

BACKGROUND: Subpectoral implant-based breast reconstruction following mastectomy commonly severs the inferior border of the pectoralis major muscle for better projection of the lower pole. This can affect a patient's postoperative motor function and result in animation deformity. Implant-based breast reconstruction using partial muscle coverage with an acellular dermal matrix (ADM) can be costly. There is an unmet clinical need for a novel surgical method for submuscular implant-based breast reconstruction. METHODS: We describe an innovative technique for submuscular implant-based breast reconstruction following mastectomy. The approach utilizes the serratus anterior muscle fascia connected to the lateral margin of the pectoralis major muscle to form a lateral tissue pocket for implant coverage. This method preserves the inferior border of the pectoralis major muscle and minimizes the size of ADM coverage. Patient satisfaction on the BREAST-Q Reconstruction Module and complications were assessed 12 months after surgery. RESULTS: The novel surgical design was safe and used minimal ADM (6 × 5cm2). Mean satisfaction with breasts was 61 ± 4.7 (range, 48-73), mean psychosocial well-being was 66 ± 10 (range, 50-93), and mean sexual well-being was 47 ± 7.8 (range, 27-70). Animation deformity was avoided by preserving the inferior border of the pectoralis major muscle. Rates of revision (7.6%) and postsurgical seroma (3.4%) were low, and capsular contracture was minimal. CONCLUSIONS: Submuscular implant-based breast reconstruction following mastectomy utilizing the serratus anterior muscle fascia connected to the lateral margin of the pectoralis major muscle to form a lateral tissue pocket for implant coverage is safe, feasible, and generates good aesthetic outcomes.

Growth, Structure, and Properties of a Multifunctional Crystal Pr2CaB10O19.

A new praseodymium-based borate crystal Pr2CaB10O19 (PCB) has been grown through the high temperature solution method. PCB crystallizes in monoclinic space group C2 with unit cell parameters of a = 10.9475(10) Å, b = 6.5343(7) Å, c = 9.0336(8) Å, ß = 91.652(3)°, and Z = 2, in which B5O12 groups and PrO10 and CaO8 polyhedra constitute the three-dimensional framework. PCB exhibits a similar second harmonic response intensity to that of La2CaB10O19 and an intense orange fluorescence emission with a long fluorescence lifetime at about 610 nm excited by a xenon lamp light of 466 nm. The band gap, partial density of states, and birefringence have been investigated via theoretical calculations.

Large Magnetocaloric Effect in Li3K9Gd3(BO3)7 Crystal Featuring Sandwich-Like Three-Dimensional Framework.

A new Gd-based borate crystal, Li3K9Gd3(BO3)7, has been successfully obtained via the high-temperature solution method using Li2O-K2O-B2O3 self-flux. It crystallizes in monoclinic space group P2/n (no. 10) with lattice parameters a = 11.3454(6) Å, b = 9.9881(4) Å, c = 11.4467(7) Å, α = γ = 90 o, ß = 114.782(7) o, and Z = 2. Li3K9Gd3(BO3)7 exhibits an intriguing sandwich-like three-dimensional (3D) framework constructed from [Gd-B-O]∞ layers, KOn (n = 6 and 8) polyhedra, and LiO4 tetrahedra, in which [Gd-B-O]∞ layers are built from two types of GdO8 polyhedra and triangular BO3 units. Magnetic measurements showed that Li3K9Gd3(BO3)7 exhibits a large magnetocaloric effect with -ΔSm = 39.3 J kg-1 K-1 at 2.0 K for ΔH = 7 T, which is slightly higher than that of the commercial gadolinium gallium garnet under the same conditions. The powder X-ray diffraction, infrared spectrum, and UV-vis-NIR diffuse reflectance spectrum were also performed to characterize Li3K9Gd3(BO3)7. The electronic band structures, partial density of states, and refractive indices of Li3K9Gd3(BO3)7 were investigated via the first-principle calculations.

Na3Bi(IO3)6: An Alkali-Metal Bismuth Iodate with Intriguing One-Dimensional [BiI6O18] Chains and Pressure-Induced Structural Transition.

An alkali-metal bismuth iodate, Na3Bi(IO3)6, was successfully obtained by the hydrothermal method for the first time and contains intriguing one-dimensional [BiI6O18] chains. High-pressure Raman spectra were carried out to investigate the structural transition of Na3Bi(IO3)6. Electronic states and anisotropic optical responses were also investigated by theoretical calculations.

Comprehensive analysis of autophagy-related prognostic genes in breast cancer.

Accumulating evidence revealed that autophagy played vital roles in breast cancer (BC) progression. Thus, the aim of this study was to investigate the prognostic value of autophagy-related genes (ARGs) and develop a ARG-based model to evaluate 5-year overall survival (OS) in BC patients. We acquired ARG expression profiling in a large BC cohort (N = 1007) from The Cancer Genome Atlas (TCGA) database. The correlation between ARGs and OS was confirmed by the LASSO and Cox regression analyses. A predictive model was established based on independent prognostic variables. Thus, time-dependent receiver operating curve (ROC), calibration plot, decision curve and subgroup analysis were conducted to determine the predictive performance of ARG-based model. Four ARGs (ATG4A, IFNG, NRG1 and SERPINA1) were identified using the LASSO and multivariate Cox regression analyses. A ARG-based model was constructed based on the four ARGs and two clinicopathological risk factors (age and TNM stage), dividing patients into high-risk and low-risk groups. The 5-year OS of patients in the low-risk group was higher than that in the high-risk group (P < 0.0001). Time-dependent ROC at 5 years indicated that the four ARG-based tool had better prognostic accuracy than TNM stage in the training cohort (AUC: 0.731 vs 0.640, P < 0.01) and validation cohort (AUC: 0.804 vs 0.671, P < 0.01). The mutation frequencies of the four ARGs (ATG4A, IFNG, NRG1 and SERPINA1) were 0.9%, 2.8%, 8% and 1.3%, respectively. We built and verified a novel four ARG-based nomogram, a credible approach to predict 5-year OS in BC, which can assist oncologists in determining effective therapeutic strategies.

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.

PURPOSE: Despite the therapeutic success of existing HER2-targeted therapies, tumors respond quite differently to them. This study aimed at figuring out genetic mutation profile of Chinese HER2-positive patients and investigating predictive factors of neoadjuvant anti-HER2 responses. METHODS: We employed two cohorts. The first cohort was comprised of 181 HER2-positive patients treated at Guangdong Provincial People's Hospital from 2012 to 2018. The second cohort included 40 patients from the first cohort who underwent HER2-targeted neoadjuvant chemotherapy. Genetic mutations were characterized using next-generation sequencing. We employed the most commonly used definition of pathological complete response (pCR)-eradication of tumor from both breast and lymph nodes (ypT0/is ypN0). RESULTS: In Chinese HER2-positive breast cancer patients, TP53 (74.6%), CDK12 (64.6%) and PIK3CA (46.4%) have the highest mutation frequencies. In cohort 2, significant differences were found between pCR and non-pCR groups in terms of the initial Ki67 status, TP53 missense mutations, TP53 LOF mutations, PIK3CA mutations and ROS1 mutations (p = 0.028, 0.019, 0.005, 0.013, 0.049, respectively). Furthermore, TP53 LOF mutations and initial Ki67 status (OR 7.086, 95% CI 1.366-36.749, p = 0.020 and OR 6.007, 95% CI 1.120-32.210, p = 0.036, respectively) were found to be predictive of pCR status. CONCLUSION: TP53 LOF mutations and initial Ki67 status in HER2-positive breast cancer are predictive of pCR status after HER2-targeted NACT.

Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.

BACKGROUND: Accumulating evidence has demonstrated that immune-related lncRNAs (IRLs) are commonly aberrantly expressed in breast cancer (BC). Thus, we aimed to establish an IRL-based tool to improve prognosis prediction in BC patients. METHODS: We obtained IRL expression profiles in large BC cohorts (N = 911) from The Cancer Genome Atlas (TCGA) database. Then, in light of the correlation between each IRL and recurrence-free survival (RFS), we screened prognostic IRL signatures to construct a novel RFS nomogram via a Cox regression model. Subsequently, the performance of the IRL-based model was evaluated through discrimination, calibration ability, risk stratification ability and decision curve analysis (DCA). RESULTS: A total of 52 IRLs were obtained from TCGA. Based on multivariate Cox regression analyses, four IRLs (A1BG-AS1, AC004477.3, AC004585.1 and AC004854.2) and two risk parameters (tumor subtype and TNM stage) were utilized as independent indicators to develop a novel prognostic model. In terms of predictive accuracy, the IRL-based model was distinctly superior to the TNM staging system (AUC: 0.728 VS 0.673, P = 0.010). DCA indicated that our nomogram had favorable clinical practicability. In addition, risk stratification analysis showed that the IRL-based tool efficiently divided BC patients into high- and low-risk groups (P < 0.001). CONCLUSIONS: A novel IRL-based model was constructed to predict the risk of 5-year RFS in BC. Our model can improve the predictive power of the TNM staging system and identify high-risk patients with tumor recurrence to implement more appropriate treatment strategies.

Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.

BACKGROUND: Recent studies have shown that selenium-binding protein 1 (SELENBP1) is significantly down-regulated in a variety of solid tumors. Nevertheless, the clinical relevance of SELENBP1 in human bladder cancer has not been described in any detail, and the molecular mechanism underlying its inhibitory role in cancer cell growth is largely unknown. METHODS: SELENBP1 expression levels in tumor tissues and adjacent normal tissues were evaluated using immunoblotting assay. The association of SELENBP1 expression, clinicopathological features, and clinical outcome was determined using publicly available dataset from The Cancer Genome Atlas bladder cancer (TCGA-BLCA) cohort. DNA methylation in SELENBP1 gene was assessed using online MEXPRESS tool. We generated stable SELENBP1-overexpression and their corresponding control cell lines to determine its potential effect on cell cycle and transcriptional activity of p21 by using flow cytometry and luciferase reporter assay, respectively. The dominant-negative mutant constructs, TAM67 and STAT1 Y701F, were employed to define the roles of c-Jun and STAT1 in the regulation of p21 protein. RESULTS: Here, we report that the reduction of SELENBP1 is a frequent event and significantly correlates with tumor progression as well as unfavorable prognosis in human bladder cancer. By utilizing TCGA-BLCA cohort, DNA hypermethylation, especially in gene body, is shown to be likely to account for the reduction of SELENBP1 expression. However, an apparent paradox is observed in its 3'-UTR region, in which DNA methylation is positively related to SELENBP1 expression. More importantly, we verify the growth inhibitory role for SELENBP1 in human bladder cancer, and further report a novel function for SELENBP1 in transcriptionally modulating p21 expression through a p53-independent mechanism. Instead, ectopic expression of SELENBP1 pronouncedly attenuates the phosphorylation of c-Jun and STAT1, both of which are indispensable for SELENBP1-mediated transcriptional induction of p21, thereby resulting in the G0/G1 phase cell cycle arrest in bladder cancer cell. CONCLUSIONS: Taken together, our findings provide clinical and molecular insights into improved understanding of the tumor suppressive role for SELENBP1 in human bladder cancer, suggesting that SELENBP1 could potentially be utilized as a prognostic biomarker as well as a therapeutic target in future cancer therapy.

Gadolinium-Rich Borate Gd17.33(BO3)4(B2O5)2O16 Exhibiting a Magnetocaloric Effect.

A gadolinium-rich borate Gd17.33(BO3)4(B2O5)2O16 was successfully grown by the high-temperature solution method using the Rb2O-B2O3 flux. The crystal crystallizes in centrosymmetric space group C2/m with lattice constants a = 18.4300(2) Å, b = 3.7400(4) Å, c = 14.2047(16) Å, and ß = 119.8550(12)°. Two different honeycomb-like [GdO] layers alternately arrange in the order ABAB forming the three-dimensional framework, in which the isolated [B2O5] and [BO3] units fill in channels of the 12-membered and 10-membered [GdO] polyhedral rings, respectively. The UV cutoff edge of Gd17.33(BO3)4(B2O5)2O16 is less than 240 nm. The maximum -ΔSm,max is 26.53 J kg-1 K-1 or 174.70 mJ cm-3 K-1 (T = 4.4 K and ΔH = 7 T) as investigated by the isothermal magnetization method.

LiGaP2O7: A Potential UV Nonlinear-Optical Crystal.

A new noncentrosymmetric pyrophosphate, LiGaP2O7, is designed and synthesized by a reasonable energy-band regulation engineering strategy with isovalent substitution. The title compound crystallizes in the monoclinic space group P21 (No. 4) with lattice parameters a = 4.7593(10) Å, b = 7.9586(16) Å, c = 6.8940(14) Å, and Z = 2, which is the isomorphic compound of LiMP2O7 (M = Fe, Cr). Compared with LiMP2O7, LiGaP2O7 exhibits a wide band gap of 4.56 eV due to no d-d electronic transitions. Meanwhile, good phase-matching ability and a moderate second-harmonic-generation (SHG) response in LiGaP2O7 are maintained. First-principles calculations of the band structure and nonlinear-optical performance were also performed in order to gain insight into the role of the Ga-O groups in the band gap and SHG effect source.

Rb7SrY2(B5O10)3: A Rare-Earth Pentaborate with Moderate Second-Harmonic Response and Interesting Phase-Matching Behavior.

Phase-matchable (PM) capacity is an indispensable factor in evaluating the applicable prospect of a new nonlinear optical crystal. Obtaining an accurate and credible PM curve by the Kurtz-Perry method using a small single crystal is indeed crucial. Here, we reported a new borate NLO crystal Rb7SrY2(B5O10)3 (I) and studied the influence of the arrangement of micro-[B5O10] groups on its birefringence. Interestingly, the synthesized polycrystalline powder and grinded single crystal display divergent PM and non-PM behavior, respectively. Combining theoretical calculations and analysis, I is demonstrated to be non-phase matchable for the second-harmonic generation (SHG) process of a 1064 nm laser.